Search

IntroductionThe understanding of the pathophysiology of multiple sclerosis (MS) has evolved alongside the characterization of cytokines and chemokines in cerebrospinal fluid (CSF) and serum. However, the complex interplay of pro- and anti-inflammatory cytokines and chemokines in different body fluids in people with MS (pwMS) and their association with disease progression is still not well understood and needs further investigation. Therefore, the aim of this study was to profile a total of 65 cytokines, chemokines, and related molecules in paired serum and CSF samples of pwMS at disease onset.MethodsMultiplex bead-based assays were performed and baseline routine laboratory diagnostics, magnetic resonance imaging (MRI), and clinical characteristics were assessed. Of 44 participants included, 40 had a relapsing–remitting disease course and four a primary progressive MS.ResultsThere were 29 cytokines and chemokines that were significantly higher in CSF and 15 in serum. Statistically significant associations with moderate effect sizes were found for 34 of 65 analytes with sex, age, CSF, and MRI parameters and disease progression.DiscussionIn conclusion, this study provides data on the distribution of 65 different cytokines, chemokines, and related molecules in CSF and serum in newly diagnosed pwMS.

Summary: Background: Inter-individual courses of multiple sclerosis (MS) are extremely variable. The objective of this study was to investigate whether κ-free light chain (κ-FLC) index and serum neurofilament light (sNfL) have an additive predictive value for MS disease activity. Methods: Patients with early MS who had cerebrospinal fluid (CSF) and serum sampling at disease onset were followed for four years. At baseline, age, sex, disease duration, number of T2-hyperintense (T2L), and contrast-enhancing T1 lesions (CEL) on MRI were determined. During follow-up, the occurrence of a second clinical attack and start of disease-modifying treatment (DMT) were registered. κ-FLC was measured by nephelometry, and κ-FLC index calculated as [CSF κ-FLC/serum κ-FLC]/albumin quotient. sNfL was determined by single-molecule array, and age- and body-mass-index adjusted Z scores were calculated. Findings: A total of 86 patients at a mean age of 33 ± 10 years and with a female predominance of 67% were included; 36 (42%) patients experienced a second clinical attack during follow-up. Cox regression analysis adjusted for age, sex, T2L, CEL, disease and follow-up duration, and DMT use during follow-up revealed that both κ-FLC index as well as sNfL Z score independently predict time to second clinical attack. The chance for freedom of relapse within 12 months was 2% in patients with high levels of κ-FLC index (>100) and high sNfL Z score (>3), 30% in patients with high κ-FLC index (>100) and lower sNfL Z score (≤3), 70% in patients with lower κ-FLC index (≤100) but high sNfL Z score (>3), and 90% in patients with lower levels of κ-FLC index (≤100) and sNfL Z score (≤3). Interpretation: κ-FLC index and sNfL Z score have an additive predictive value for early MS disease activity that is independent of known predictors. Funding: This study was funded by a grant of the charitable foundation of the Austrian Multiple Sclerosis Society.

As electrolyte materials for proton conductive fuel cells, perovskite-type materials such as barium cerates and barium zirconates have received a lot of attention due to their high protonic conduction at intermediate temperatures. Yet, the crystalline structure and the microstructure of the electrolyte layers are of the utmost importance that define the resulting protonic conductivity. The aim of this research was to investigate the formation of doped/undoped BCO and BZO thin films using e-beam vapor deposition and to analyze the influence of the formation parameters on the microstructural and crystallographic properties. Crystalline structure and microstructure were investigated by X-ray diffractometer and scanning electron microscope, while the elemental composition of the resulting thin films was analyzed by an energy-dispersive X-ray spectroscope. It was found that the formed thin films were highly dense and consisted of the oriented columnar grains. The crystallinity of the thin films was strongly expressed with the predominant crystallographic orientations for undoped/doped barium cerates. Yttrium dopant had an influence on the lattice parameters and crystallite sizes. With the chosen technological parameters allowed to both, barium cerates and barium zirconates did not form carbonates and did not experience the degradation process.

Mitral annular disjunction (MAD) represents the detachment of the mitral leaflet hinge-point from the ventricular myocardium. Its role in patients with ST-segment-elevation myocardial infarction (STEMI) is unknown. This study aims to investigate the prevalence of MAD by cardiac magnetic resonance imaging (CMR) in STEMI-patients and its association with serious adverse events. STEMI-patients (n = 621) underwent CMR 4 days [interquartile range (IQR) 2–5] after percutaneous coronary intervention. Presence and longitudinal extent of MAD were obtained in long-axis cine-images, infarct characteristics in late gadolinium enhancement-images. During a median follow-up time of 366 days (IQR 136–454), patients were observed for the occurrence of major adverse cardiac events (MACE), comprising death, myocardial reinfarction, and congestive heart failure. Overall, 307 patients (49 %) had MAD. Longitudinal MAD-distance was 4.6 ± 1.7 mm and the P3-segment was affected most frequently (n = 262, 85 % of MAD-patients). MAD-patients had a significantly smaller infarct size, lower prevalence of microvascular obstruction, and intramyocardial hemorrhage as well as a higher ejection fraction (all p < 0.03). During follow-up period, MACE occurred in 52 patients (8 %) and did not show significant difference between patients with and without MAD (7 % vs. 9 %, p = 0.424). Cardiovascular death occurred significantly more often in patients without MAD (n = 10, 3.2 % vs. n = 2, 0.7 %, p = 0.021). MAD is a rather common finding in patients presenting with STEMI. Patients with MAD had less severe infarct characteristics, however, they were not more commonly affected by MACE. Further confirmation and longer follow-up intervals are necessary to define the exact role of MAD in STEMI patients. MAD occurred in 51 % of patients suffering ST-segment elevation myocardial infarction. Infarct parameters such as infarct size, ejection fraction, and prevalence of IMH were significantly different between these two groups, in favor of patients with disjunction. IMH, intramyocardial hemorrhage; LVMM, left ventricular myocardial mass; MAD, mitral annular disjunction; STEMI, ST-segment elevation myocardial infarction. [Display omitted] • Mitral annular disjunction (MAD) is a common finding in ST-segment-elevation myocardial infarction patients. • The P3-segment was the most frequently affected part of the mitral valve. • In our study, MAD-patients presented with less severe infarctions. • Major adverse cardiac events did not occur significantly more often in MAD-patients. [ABSTRACT FROM AUTHOR]